Chronic Pelvic Pain Syndrome, General Conservative and MedicalManagement and Palmitoylethanolamide (PEA) Efficacy

Authors

  • Marco Rinaldi Medical Director in Urology at the Western Hospital Unit “San Pio” in Castellaneta,Via del Mercato,1, Castellaneta, Italy and Resident of Urology at the University of Bari at the Azienda Ospedaliero-Universitaria Policlinico di Bari, Piazza Giulio Cesare, 11, Bari, Italy Author

DOI:

https://doi.org/10.47363/JDDT/2022(2)121

Keywords:

Chronic Pelvic Pain Syndrome, Palmitoylethanolamide

Abstract

Chronic pelvic pain syndrome is a condition of pelvic and perineal pain, not releated to other known pathologies, that lasts more than three months.


It is a disease that influences a lot people’s quality of life.


Currently there are several types of management, including conservative, medical and surgical approaches.


About medical therapy the management with phytotherapics has shown a good efficacy on pain reduction, in particular palmitoylethanolamide (PEA) has demonstrated to have a role for its anti-inflammatory and analgesic properties.

Author Biography

  • Marco Rinaldi, Medical Director in Urology at the Western Hospital Unit “San Pio” in Castellaneta,Via del Mercato,1, Castellaneta, Italy and Resident of Urology at the University of Bari at the Azienda Ospedaliero-Universitaria Policlinico di Bari, Piazza Giulio Cesare, 11, Bari, Italy

    Marco Rinaldi, Medical Director in Urology at the Western Hospital Unit “San Pio” in Castellaneta,Via del Mercato,1, Castellaneta, Italy and Resident of Urology at the University of Bari at the Azienda Ospedaliero-Universitaria Policlinico di Bari, Piazza Giulio Cesare, 11, Bari, Italy.

Downloads

Published

2022-11-07